HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Terri Cameron Selected Research

lurtotecan

3/2005Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: a trial of the national cancer institute of Canada clinical trials group.
3/2002Phase I and pharmacologic study of liposomal lurtotecan, NX 211: urinary excretion predicts hematologic toxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Terri Cameron Research Topics

Disease

6Carcinoma (Carcinomatosis)
10/2021 - 10/2017
6Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 03/2005
5Neoplasms (Cancer)
09/2022 - 03/2002
1Disease Progression
01/2020
1Asthenia
11/2019
1Fatigue
11/2019
1Nausea
11/2019
1Vomiting
11/2019
1Neoplasm Metastasis (Metastasis)
10/2017
1Ovarian Epithelial Carcinoma
03/2005
1Thrombocytopenia (Thrombopenia)
03/2002
1Neutropenia
03/2002

Drug/Important Bio-Agent (IBA)

8rucaparibIBA
10/2021 - 10/2017
6PlatinumIBA
10/2021 - 10/2017
3Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2020 - 10/2017
2Topoisomerase I InhibitorsIBA
03/2005 - 03/2002
2lurtotecanIBA
03/2005 - 03/2002
1E-3810IBA
09/2022
1Biomarkers (Surrogate Marker)IBA
01/2021
1Poly Adenosine Diphosphate RiboseIBA
01/2021
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
10/2020
1chemotactic factor inactivatorIBA
01/2020
1Hemoglobins (Hemoglobin)IBA
11/2019
1niraparibIBA
01/2019
1olaparibIBA
01/2019
1AntigensIBA
10/2017

Therapy/Procedure

5Therapeutics
01/2021 - 10/2017
5Drug Therapy (Chemotherapy)
10/2020 - 03/2005
1Intravenous Infusions
03/2002